Brickell Bio

Janssen, Brickell and ViiV are Knocking on FDA's Door
BioSpace
Sat, 10/9/21 - 10:56 pm
FDA
Janssen
Stelara
juvenile psoriatic arthritis
Brickell Bio
sofpironium bromide gel
ViiV Healthcare
HIV
Triumeq
Vical finds way out of R&D woes via reverse merger with dermatology biotech Brickell
Endpoints
Mon, 06/3/19 - 08:15 pm
Vical
M&A
Brickell Bio
Lilly CMO Robert Brown to lead Brickell Bio as it eyes phase 3 dermatology trials
Fierce Biotech
Mon, 11/19/18 - 04:46 pm
Brickell Bio
Eli Lilly
Robert Brown
dermatology